[logo] HealthTree Foundation
more_vert

Joseph G. Jurcic, MD

Director, Hematologic Malignancies Section

Specialities: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoma, Lymphoblastic Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelomonocytic Leukemia, Myeloproliferative Neoplasm, Myelodysplastic Syndromes, Essential Thrombocythemia, Hairy Cell Leukemia, Large Granular Lymphocytic Leukemia, Leukemia, Myelofibrosis, Polycythemia Vera

Spoken languages: English

Clinical Expertise

  • Acute Leukemia
  • Acute Lymphocytic Leukemia
  • Acute Myeloid Leukemia
  • Aplastic Anemia
  • Chronic Leukemia
  • Chronic Lymphocytic Leukemia
  • Chronic Myelogenous Leukemia
  • CMML (Chronic Myelomonocytic Leukemia)
  • Essential Thrombocythemia
  • Hairy Cell Leukemia
  • Hematologic Malignancy
  • Hemolytic Anemia
  • Immune Thrombocytopenia
  • Large Granular Lymphocytic Leukemia
  • Leukemia
  • Lymphoblastic Leukemia
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Myeloproliferative Disease
  • Polycythemia Vera
  • Rare Diseases & Myeloproliferative Neoplasms

About

Dr. Joseph Jurcic is a Professor of Medicine at Columbia University Medical Center and the Director of the Hematologic Malignancies Section within the Division of Hematology/Oncology. He specializes in Medical Oncology and focuses on leukemia, myelodysplastic syndromes, and myeloproliferative disorders. Based in New York, NY, Dr. Jurcic is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. He received his M.D. from the Perelman School of Medicine at the University of Pennsylvania and completed his training at Barnes-Jewish Hospital and Memorial Sloan Kettering Cancer Center. He is board-certified in both Medical Oncology and Hematology.

Dr. Jurcic's clinical expertise includes the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndromes. His research interests encompass acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy, developing novel small molecule inhibitors, and molecular monitoring of minimal residual disease. Recognized as one of New York Magazine's "Best Doctors" from 2014 to 2024, he has authored or co-authored over 80 articles and book chapters. He has served as the principal investigator on more than 25 clinical trials. Additionally, Dr. Jurcic lectures at national and international conferences and is the Leukemia Section Editor for The Oncologist.

Location

Columbia - Herbert Irving Comprehensive Cancer Center: 161 Fort Washington Ave, New York, NY 10032, USA

newsletter icon

Get the Latest Lymphoblastic Lymphoma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Together we care.

Together we cure.

100% of every dollar you give supports our life-changing mission.